Abstract Background We examined the association between cannabis use and cardiovascular outcomes among the general population, among never‐tobacco smokers, and among younger individuals. Methods and Results This is a population‐based,…
Keyword: ∆9-tetrahydrocannabinol (THC)
Use of Cannabis in Fetal Alcohol Spectrum Disorder
Please use this link to access this publication. Abstract Background: Fetal alcohol spectrum disorder (FASD) has been recently estimated to afflict up to 5% of American children. Most of these children…
Autism and associated disorders: cannabis as a potential therapy
Abstract Autism spectrum disorder (ASD) is a group of disabilities with impairments in physical, verbal, and behavior areas. Regardless the growing frequency of autism, no medicine has been formed for…
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
Please use this link to access this publication. ABSTRACT Objective: Debilitating pain, occurring in 50–70% of multiple sclerosis (MS) patients, is poorly understood and infrequently studied. We summarized efficacy and safety…
Evidence for the Risks and Consequences of Adolescent Cannabis Exposure
Please use this link to access this publication. Abstract Objective This review of the scientific literature examines the potential adult sequelae of exposure to cannabis and related synthetic cannabinoids in adolescence. We examine the…
Role of cannabis in cardiovascular disorders
Abstract The growing popularity of medical and recreational consumption of cannabis, especially among the youth, raises immediate concerns regarding its safety and long-terms effects. The cardiovascular effects of cannabis are…
Medical Cannabinoids in Children and Adolescents: A Systematic Review
Please use this link to access this publication. Abstract CONTEXT: Legalization of medical marijuana in many states has led to a widening gap between the accessibility and the evidence for…
An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis
Please use this link to access this publication. Abstract The majority of patients with multiple sclerosis (MS) develop troublesome lower urinary tract symptoms (LUTS). Anecdotal reports suggest that cannabis may…
Adverse effects of medical cannabinoids: a systematic review
Abstract Background: The therapeutic use of cannabis and cannabis-based medicines raises safety concerns for patients, clinicians, policy-makers, insurers, researchers and regulators. Although the efficacy of cannabinoids is being increasingly demonstrated in…
Cannabis and Anxiety: A Critical Review
Abstract Introduction: Cannabis has been reported to have both anxiogenic and anxiolytic effects. Habitual cannabis use has been associated with anxiety disorders (AD). The causal pathways and mechanisms underlying the association…